QurAlis has appointed Doug Williamson as the Chief Medical Officer and Jason Brown as the Chief Financial Officer. Kasper Roet, PhD, the CEO, expresses confidence in their ability to contribute to the company's next phase of growth and advancement in clinical development. The company also announced the appointment of Shafique Virani to its board of directors.
Company Information
Company
QurAlis
Location
Cambridge, Massachusetts, United States
About
QurAlis is a pioneering neuroscience company dedicated to developing precision medicines that target the root causes of neurodegenerative and neurological diseases. With leading expertise in amyotrophic lateral sclerosis (ALS), the company is committed to translating scientific breakthroughs into transformative therapies. Guided by collaboration, scientific rigor, and compassion, QurAlis is advancing a robust pipeline of disease-modifying treatments driven by genetics and clinical biomarkers to improve the lives of patients with severe neurological conditions.
Fundz sees it the moment QurAlis changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeBiotechnologyHealthcareHealth CareTherapeutics